Skip to main content
. 2023 Nov 19;11(1):79–96. doi: 10.1007/s40744-023-00620-7

Fig. 2.

Fig. 2

Overall change in lymphocyte subsets in patients with ARDs. (A) CD4+. (B) CD8+. (C) NK. (D) Th1. (E) Th2. (F) Th17.(G) Treg. (H) Th1/Th2 (I) Th17/Treg. SMD standardized mean difference, CI confidence interval, ARDs autoimmune rheumatic diseases, NK natural killer, TH T helper cell, Treg regulatory T cells